122
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence of Culture-Confirmed Tuberculosis Among Patients with Nontuberculous Mycobacterial Disease

, , & ORCID Icon
Pages 3097-3101 | Published online: 17 Jun 2022

References

  • Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535. doi:10.1183/13993003.00535-2020
  • Jing H, Wang H, Wang Y, et al. Prevalence of nontuberculous mycobacteria infection, China, 2004–2009. Emerg Infect Dis. 2012;18(3):527–528. doi:10.3201/eid1803.110175
  • Jing H, Tan W, Deng Y, et al. Diagnostic delay of pulmonary nontuberculous mycobacterial infection in China. Multidiscip Respir Med. 2014;9(1):48. doi:10.1186/2049-6958-9-48
  • Xu D, Han C, Wang MS, Wang JL. Increasing prevalence of non-tuberculous mycobacterial infection from 2004–2009 to 2012–2017: a laboratory-based surveillance in China. J Infect. 2018;76(4):422–424. doi:10.1016/j.jinf.2017.12.007
  • Wang MS, Wang JL, Wang XF. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China. BMC Pulm Med. 2016;16(1):163. doi:10.1186/s12890-016-0320-3
  • Deng Y, Li Y, Wang F, et al. Tuberculosis prevention in healthcare workers in China 10 years after the severe acute respiratory syndrome pandemic. ERJ Open Res. 2015;1(1):00015–2015. doi:10.1183/23120541.00015-2015
  • Mbeha B, Mine M, Motswaledi MS, Dewar J. Nontuberculous Mycobacteria, Botswana, 2011–2014. Emerg Infect Dis. 2019;25(7):1401–1403. doi:10.3201/eid2507.181440
  • Chunfang W, Jihong R, Yu W, et al. Prevalence of nontuberculous mycobacterial disease in the Changchun District of China. Curr Microbiol. 2021;78(4):1643–1647. doi:10.1007/s00284-021-02422-y
  • Tan Y, Deng Y, Yan X, et al. Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: a prospective surveillance study. J Infect. 2021;83(1):46–53. doi:10.1016/j.jinf.2021.05.019
  • El Amin NM, Hanson HS, Pettersson B, Petrini B, Von Stedingk LV. Identification of non-tuberculous mycobacteria: 16S rRNA gene sequence analysis vs. conventional methods. Scand J Infect Dis. 2000;32(1):47–50. doi:10.1080/00365540050164218
  • Huang JJ, Li YX, Zhao Y, et al. Prevalence of nontuberculous mycobacteria in a tertiary hospital in Beijing, China, January 2013 to December 2018. BMC Microbiol. 2020;20(1):158. doi:10.1186/s12866-020-01840-5
  • He Y, Zhang YA, Wang MS. Stool culture for diagnosis of nontuberculous mycobacteria pulmonary disease: an indirect evidence. J Infect. 2021;83:607–635. doi:10.1016/j.jinf.2021.08.002
  • Varghese B, Al-Hajoj S. A global update on rare non-tuberculous mycobacteria in humans: epidemiology and emergence. Int J Tuberc Lung Dis. 2020;24(2):214–223. doi:10.5588/ijtld.19.0194
  • Lin CK, Yang YH, Lu ML, et al. Incidence of nontuberculous mycobacterial disease and coinfection with tuberculosis in a tuberculosis-endemic region: a population-based retrospective cohort study. Medicine. 2020;99(52):e23775. doi:10.1097/MD.0000000000023775
  • Bonnet M, San KC, Pho Y, et al. Nontuberculous mycobacteria infections at a provincial reference hospital. Cambodia Emerg Infect Dis. 2017;23(7):1139–1147. doi:10.3201/eid2307.170060
  • Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-2
  • Yilmaz N, Ucar EY, Saglam L. Mycobacterium tuberculosis and nontuberculous mycobacteria coinfection of the lungs. Turk Thorac J. 2017;18(1):23–26. doi:10.5152/TurkThoracJ.2017.16034
  • Sharma K, Gautam N, Sharma M, et al. Ocular mycobacteriosis-dual infection of M. tuberculosis complex with M. fortuitum and M. bovis. J Ophthalmic Inflamm Infect. 2017;7(1):2. doi:10.1186/s12348-016-0121-0
  • Izadi N, Derakhshan M, Samiei A, Ghazvini K. Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: a case report. Respir Med Case Rep. 2015;15:12–13. doi:10.1016/j.rmcr.2014.11.006
  • Wallace RJ, Brown BA, Griffith DE, et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med. 1994;149(5):1335–1341. doi:10.1164/ajrccm.149.5.8173775
  • Griffith DE, Eagle G, Thomson R, et al. Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study. Am J Respir Crit Care Med. 2018;198(12):1559–1569. doi:10.1164/rccm.201807-1318OC
  • Lan R, Yang C, Lan L, et al. Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China. Int J Tuberc Lung Dis. 2011;15(12):1669–1675. doi:10.5588/ijtld.11.0036
  • Andrejak C, Nielsen R, Thomsen VO, Duhaut P, Sorensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68(3):256–262. doi:10.1136/thoraxjnl-2012-201772
  • Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis. 2009;15(10):1556–1561. doi:10.3201/eid1510.090310
  • Fusco da Costa AR, Falkinham JO, Lopes ML, et al. Occurrence of nontuberculous mycobacterial pulmonary infection in an endemic area of tuberculosis. PLoS Negl Trop Dis. 2013;7(7):e2340. doi:10.1371/journal.pntd.0002340
  • Hsing SC, Weng SF, Cheng KC, et al. Increased risk of pulmonary tuberculosis in patients with previous non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis. 2013;17(7):928–933. doi:10.5588/ijtld.12.0675